[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371963-105":59,"doc-detail-371963-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","rational-design-of-metalorganic-frameworks-for-pancreatic-cancer-therapy-from-machine-learning-screening-to-in-vivo-efficacy-371963","Rational Design of Metal–Organic Frameworks for Pancreatic Cancer Therapy - from Machine Learning Screening to In Vivo Efficacy","","Cancer therapies have improved survival rates, yet metastatic and drug-resistant pancreatic cancer remains difficult to treat with poor prognoses and limited options. Enhancing tumor drug bioavailability while minimizing off-target effects is essential. This study applies machine learning and molecular simulations to screen metal–organic frameworks for gemcitabine, paclitaxel, and SN-38, identifying PCN-222. Loaded MOF formulations improve colloidal stability, biocompatibility, and release behavior, and show strong in vitro and long-term (12-month) stability, with in vivo efficacy in tumor-bearing mice.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rational-design-of-metalorganic-frameworks-for-pancreatic-cancer-therapy-from-machine-learning-screening-to-in-vivo-efficacy-371963/371963/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rational-design-of-metalorganic-frameworks-for-pancreatic-cancer-therapy-from-machine-learning-screening-to-in-vivo-efficacy-371963/371963.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"What were the key in vivo findings in pancreatic tumor-bearing mice?","Question",{"text":112,"@type":113},"Paclitaxel-loaded PCN-222, especially when administered locally with a hydrogel, significantly reduced metastatic spread and tumor growth compared with free paclitaxel.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},371963,1790468963,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":36,"preview_page_count":19,"preview_urls":137},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","RESEARCH ARTICLE   \n[www.advmat.de](www.advmat.de)  \nRational Design of Metal–Organic Frameworks for Pancreatic Cancer Therapy: from Machine Learning Screening to In Vivo Eﬃcacy  \nFrancesca Melle, Dhruv Menon, João Conniot, Jon Ostolaza-Paraiso, Sergio Mercado, Jhenifer Oliveira, Xu Chen, Bárbara B. Mendes, João Conde,* and David Fairen-Jimenez*  \nDespite improvements in cancer survival rates, metastatic and surg  \nery-resistant cancers, such as pancreatic cancer, remain challenging, with poor prognoses and limited treatment options. Enhancing drug bioavailability in tumors, while minimizing oﬀ-target eﬀects, is crucial. Metal–organic frameworks (MOFs) have emerged as promising drug delivery vehicles owing to their high loading capacity, biocompatibility, and functional tunability. However, the vast chemical diversity of MOFs complicates the rational design of biocompatible materials. This study employed machine learning and molecular simulations to identify MOFs suitable for encapsulating gemcitabine, paclitaxel, and SN-38, and identiﬁed PCN-222 as an optimal candidate. Following drug loading, MOF formulations are improved for colloidal stability and biocompatibility. In vitro studies on pancreatic cancer cell lines have shown high biocompatibility, cellular internalization, and delayed drug release. Long-term stability tests demonstrated a consistent performance over 12 months. In vivo studies in pancreatic tumor-bearing mice revealed that paclitaxel-loaded PCN-222, particularly with a hydrogel for local administration, signiﬁcantly reduced metastatic spread and tumor growth compared to the free drug. These ﬁndings underscore the potential of PCN-222 as an eﬀective drug delivery system for the treatment of hard-to-treat cancers.  \nexpected to rise to over 16 million by 2040 . [1] Despite advancements in cancer treatmentsand improved survival rates in recent years, the heterogeneous nature of cancer demands the development of new therapeutic strategies. This is particularly relevant for the so-called “hard-to-treat” cancers, which continue to exhibit alarmingly high mortality rates with little to no progress in outcomes over the past 20 years. [2] An example is pancreatic ductal adenocarcinoma (PDAC), the most common and deadly form of pancreatic cancer known for its exceptionally high mortality rate. [2,3] Despite accounting for only 3.3% of all new cancer cases in the United States, pancreatic cancer ranks as the fourth leading cause of cancer-related deaths in males and females, with almost 7% of all cancer deaths. [4,5] The 5-year relative survival rate for pancreatic cancer remains below 10%, starkly contrasting the higher survival rates seen in other common cancers such as breast (90.8%), prostate (97.1%), and thyroid (98.5%) . [6] This disparity highlights the aggressive nature of pancreatic cancer and the signiﬁcant challenges it poses  \n1. Introduction  \nCancer remains the second leading cause of mortality worldwide, responsible for ≈10 million deaths annually—a number  \nin early diagnosis and eﬀective treatment. Pancreatic cancer is often diagnosed in later stages, which signiﬁcantly limits treatment options. Only a small percentage of patients (15-20%) are eligible for surgery, needing to rely on combination chemotherapy as the  \nF. Melle, D. Menon, J. Ostolaza-Paraiso, S. Mercado, X. Chen,  \nD. Fairen-Jimenez  \nThe Adsorption & Advanced Materials Laboratory (AAML) Department of Chemical Engineering & Biotechnology University of Cambridge  \nPhilippa Fawcett Drive, Cambridge CB3 0AS, UK  \nE-mail: [df334@cam.ac.uk](df334@cam.ac.uk)  \nThe ORCID identiﬁcation number(s) for the author(s) of this article can be found under [https://doi.org/10.1002/adma.202412757](https://doi.org/10.1002/adma.202412757)[ ](https://doi.org/10.1002/adma.202412757)© 2025 The Author(s). Advanced Materials published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use,","cbCaiv12LZeTJ0r8","https://ap.wps.com/l/cbCaiv12LZeTJ0r8","pdf",9485816,16,"English","# Introduction\n## Metal–organic frameworks for drug delivery\n## Study approach: machine learning screening and simulations\n## Formulation improvements and in vitro evaluation\n## Long-term stability and in vivo efficacy","[{\"question\":\"What were the key in vivo findings in pancreatic tumor-bearing mice?\",\"answer\":\"Paclitaxel-loaded PCN-222, especially when administered locally with a hydrogel, significantly reduced metastatic spread and tumor growth compared with free paclitaxel.\"}]","Rational Design of Metal–Organic Frameworks for Pancreatic Cancer Therapy - from Machine Learning Screening to In Vivo Efficacy | PDF",1790193334,[138,142,146,150],{"page_no":8,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a78c731db4eefaa85782b68557bcc5eb.webp",983,1291,{"page_no":14,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5db158a9abb002e64d1fe1f27927b2eb.webp",982,1290,{"page_no":81,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21c0f13c656a909ea591ed0a4a3f4ea4.webp",981,1289,{"page_no":19,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e4806e27cef9a9c8156a8d0aa758e09.webp",980,1287]